Clinical Trial Update: Rapamycin and Regulatory T Cells in Kidney Transplantation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating sirolimus (Rapamycin) with regulatory T-cell therapy in kidney transplantation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Rapamycin (sirolimus)
• Regulatory T cell therapy (regulatory T cells)

Snippet

Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia | Conditions: Kidney Transplantation | Phase 2 | Status: COMPLETED